XYREM RELIEVES PAIN IN PATIENTS WITH FIBROMYALGIA, SHOWS

Patients with fibromyalgia syndrome taking Orphan Medical's Xyrem (sodium oxybate) in a Phase II clinical trial experienced significant pain relief.

The eight-week, randomized, double-blind, placebo-controlled study examined two dosages of Xyrem (4.5 g per day or 6 g per day) taken in two equally divided doses (the first at bedtime and the second 2.5 to four hours later). The intent-to-treat population included 188 patients, of whom 147 completed the trial.